Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT633 | Organism | Leishmania donovani | Leishmania donovani | Inhibition | = | 67.43 | % | PubChem BioAssay data set |
NPT6376 | Individual Protein | Trypanothione reductase | Leishmania donovani | Inhibition | = | 82.76 | % | PubChem BioAssay data set |
NPT6376 | Individual Protein | Trypanothione reductase | Leishmania donovani | Inhibition | = | 51.66 | % | PubChem BioAssay data set |
NPT6376 | Individual Protein | Trypanothione reductase | Leishmania donovani | Inhibition | = | 67.76 | % | PubChem BioAssay data set |
NPT71 | Cell Line | HEK293 | Homo sapiens | Activity | = | 89.63 | % | 19689125 |
NPT633 | Organism | Leishmania donovani | Leishmania donovani | IC50 | = | 9000 | nM | 19689125 |
NPT633 | Organism | Leishmania donovani | Leishmania donovani | IC50 | = | 5016 | nM | 19689125 |
NPT633 | Organism | Leishmania donovani | Leishmania donovani | Inhibition | = | 39.91 | % | 17477572 |
NPT633 | Organism | Leishmania donovani | Leishmania donovani | Activity | = | 2.51 | % | 10.1039/C0MD00252F |
NPT633 | Organism | Leishmania donovani | Leishmania donovani | Activity | = | 10 | % | 10.1039/C0MD00252F |
NPT633 | Organism | Leishmania donovani | Leishmania donovani | Activity | = | 50.9 | % | 19835393 |
NPT633 | Organism | Leishmania donovani | Leishmania donovani | Activity | = | 36.59 | % | 12608850 |
NPT633 | Organism | Leishmania donovani | Leishmania donovani | Survival | < | 28 | day | 17500572 |
NPT6376 | Individual Protein | Trypanothione reductase | Leishmania donovani | Inhibition | = | 62.67 | % | 10.1039/C4MD00406J |
NPT6376 | Individual Protein | Trypanothione reductase | Leishmania donovani | Inhibition | = | 46.87 | % | 19001116 |
NPT6376 | Individual Protein | Trypanothione reductase | Leishmania donovani | Inhibition | = | 97.66 | % | 19015330 |
NPT71 | Cell Line | HEK293 | Homo sapiens | Activity | = | 48.62 | % | 10.1021/np50086a008 |
NPT6376 | Individual Protein | Trypanothione reductase | Leishmania donovani | Inhibition | = | 78.87 | % | 17300184 |
NPT6376 | Individual Protein | Trypanothione reductase | Leishmania donovani | Inhibition | = | 95.3 | % | 17300184 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC96599 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.979 | High Similarity | NPC117346 |
0.979 | High Similarity | NPC240592 |
0.9645 | High Similarity | NPC296659 |
0.9645 | High Similarity | NPC202391 |
0.9592 | High Similarity | NPC475484 |
0.9586 | High Similarity | NPC475379 |
0.9507 | High Similarity | NPC251062 |
0.9507 | High Similarity | NPC184464 |
0.9452 | High Similarity | NPC158546 |
0.9452 | High Similarity | NPC289021 |
0.9437 | High Similarity | NPC186296 |
0.9396 | High Similarity | NPC475378 |
0.9296 | High Similarity | NPC7518 |
0.9296 | High Similarity | NPC159387 |
0.9296 | High Similarity | NPC154262 |
0.9296 | High Similarity | NPC137501 |
0.9184 | High Similarity | NPC478234 |
0.9184 | High Similarity | NPC478236 |
0.9155 | High Similarity | NPC31745 |
0.9155 | High Similarity | NPC220936 |
0.9145 | High Similarity | NPC179914 |
0.9128 | High Similarity | NPC194705 |
0.9067 | High Similarity | NPC229354 |
0.9021 | High Similarity | NPC49597 |
0.9 | High Similarity | NPC478235 |
0.898 | High Similarity | NPC143246 |
0.898 | High Similarity | NPC475539 |
0.898 | High Similarity | NPC474268 |
0.898 | High Similarity | NPC119773 |
0.898 | High Similarity | NPC473147 |
0.8973 | High Similarity | NPC77922 |
0.8973 | High Similarity | NPC194938 |
0.8973 | High Similarity | NPC473281 |
0.8968 | High Similarity | NPC145847 |
0.8912 | High Similarity | NPC475528 |
0.891 | High Similarity | NPC109990 |
0.8904 | High Similarity | NPC293154 |
0.8904 | High Similarity | NPC475213 |
0.8904 | High Similarity | NPC152796 |
0.8897 | High Similarity | NPC46644 |
0.8882 | High Similarity | NPC478232 |
0.8873 | High Similarity | NPC169398 |
0.8867 | High Similarity | NPC35097 |
0.8859 | High Similarity | NPC120728 |
0.8851 | High Similarity | NPC212808 |
0.8844 | High Similarity | NPC63304 |
0.8839 | High Similarity | NPC138993 |
0.8803 | High Similarity | NPC470143 |
0.8803 | High Similarity | NPC322503 |
0.8792 | High Similarity | NPC473149 |
0.8776 | High Similarity | NPC237872 |
0.8776 | High Similarity | NPC88754 |
0.8776 | High Similarity | NPC302286 |
0.8776 | High Similarity | NPC263397 |
0.8776 | High Similarity | NPC116104 |
0.8726 | High Similarity | NPC476011 |
0.8718 | High Similarity | NPC208676 |
0.8718 | High Similarity | NPC130489 |
0.8718 | High Similarity | NPC474936 |
0.871 | High Similarity | NPC187205 |
0.8693 | High Similarity | NPC257847 |
0.869 | High Similarity | NPC65262 |
0.869 | High Similarity | NPC101686 |
0.869 | High Similarity | NPC469364 |
0.8688 | High Similarity | NPC21956 |
0.8684 | High Similarity | NPC474620 |
0.8679 | High Similarity | NPC130730 |
0.8679 | High Similarity | NPC301910 |
0.8675 | High Similarity | NPC161955 |
0.8662 | High Similarity | NPC254819 |
0.8658 | High Similarity | NPC210330 |
0.8627 | High Similarity | NPC203664 |
0.8618 | High Similarity | NPC69367 |
0.8608 | High Similarity | NPC206815 |
0.86 | High Similarity | NPC37838 |
0.8591 | High Similarity | NPC478240 |
0.8581 | High Similarity | NPC296643 |
0.8543 | High Similarity | NPC18789 |
0.8523 | High Similarity | NPC478250 |
0.8497 | Intermediate Similarity | NPC147224 |
0.8493 | Intermediate Similarity | NPC472132 |
0.8471 | Intermediate Similarity | NPC329997 |
0.8456 | Intermediate Similarity | NPC284957 |
0.8447 | Intermediate Similarity | NPC282551 |
0.8442 | Intermediate Similarity | NPC269914 |
0.8442 | Intermediate Similarity | NPC478249 |
0.8418 | Intermediate Similarity | NPC469384 |
0.8415 | Intermediate Similarity | NPC195972 |
0.8414 | Intermediate Similarity | NPC114116 |
0.8408 | Intermediate Similarity | NPC478248 |
0.8408 | Intermediate Similarity | NPC10945 |
0.8403 | Intermediate Similarity | NPC281798 |
0.8367 | Intermediate Similarity | NPC471345 |
0.8366 | Intermediate Similarity | NPC308178 |
0.8366 | Intermediate Similarity | NPC189631 |
0.8354 | Intermediate Similarity | NPC49173 |
0.8354 | Intermediate Similarity | NPC475663 |
0.8354 | Intermediate Similarity | NPC286919 |
0.8333 | Intermediate Similarity | NPC478241 |
0.8333 | Intermediate Similarity | NPC89693 |
0.8333 | Intermediate Similarity | NPC17567 |
0.8333 | Intermediate Similarity | NPC229548 |
0.8313 | Intermediate Similarity | NPC475613 |
0.8301 | Intermediate Similarity | NPC470330 |
0.8276 | Intermediate Similarity | NPC46137 |
0.8276 | Intermediate Similarity | NPC235294 |
0.8276 | Intermediate Similarity | NPC475824 |
0.8276 | Intermediate Similarity | NPC478255 |
0.8258 | Intermediate Similarity | NPC267469 |
0.8258 | Intermediate Similarity | NPC87630 |
0.8258 | Intermediate Similarity | NPC116292 |
0.8258 | Intermediate Similarity | NPC179128 |
0.8252 | Intermediate Similarity | NPC173150 |
0.8252 | Intermediate Similarity | NPC156692 |
0.8252 | Intermediate Similarity | NPC106677 |
0.8252 | Intermediate Similarity | NPC471882 |
0.8252 | Intermediate Similarity | NPC471881 |
0.8252 | Intermediate Similarity | NPC288416 |
0.8252 | Intermediate Similarity | NPC35288 |
0.8252 | Intermediate Similarity | NPC45224 |
0.8247 | Intermediate Similarity | NPC23677 |
0.8242 | Intermediate Similarity | NPC271755 |
0.8242 | Intermediate Similarity | NPC149502 |
0.8242 | Intermediate Similarity | NPC470685 |
0.8242 | Intermediate Similarity | NPC254071 |
0.8242 | Intermediate Similarity | NPC222665 |
0.8239 | Intermediate Similarity | NPC226759 |
0.8239 | Intermediate Similarity | NPC4747 |
0.8239 | Intermediate Similarity | NPC104275 |
0.8235 | Intermediate Similarity | NPC291153 |
0.8235 | Intermediate Similarity | NPC208293 |
0.8235 | Intermediate Similarity | NPC473867 |
0.8235 | Intermediate Similarity | NPC320734 |
0.8228 | Intermediate Similarity | NPC172920 |
0.8228 | Intermediate Similarity | NPC156624 |
0.8217 | Intermediate Similarity | NPC299706 |
0.8217 | Intermediate Similarity | NPC115466 |
0.8217 | Intermediate Similarity | NPC245615 |
0.8217 | Intermediate Similarity | NPC61604 |
0.8207 | Intermediate Similarity | NPC319995 |
0.8207 | Intermediate Similarity | NPC289415 |
0.8205 | Intermediate Similarity | NPC77310 |
0.8199 | Intermediate Similarity | NPC477627 |
0.8194 | Intermediate Similarity | NPC225307 |
0.8194 | Intermediate Similarity | NPC478242 |
0.8187 | Intermediate Similarity | NPC76211 |
0.8182 | Intermediate Similarity | NPC61181 |
0.8182 | Intermediate Similarity | NPC276047 |
0.8182 | Intermediate Similarity | NPC471157 |
0.8182 | Intermediate Similarity | NPC267733 |
0.8163 | Intermediate Similarity | NPC19719 |
0.8163 | Intermediate Similarity | NPC477281 |
0.8163 | Intermediate Similarity | NPC477280 |
0.816 | Intermediate Similarity | NPC318472 |
0.816 | Intermediate Similarity | NPC180586 |
0.8158 | Intermediate Similarity | NPC469367 |
0.8158 | Intermediate Similarity | NPC204644 |
0.8156 | Intermediate Similarity | NPC52097 |
0.8151 | Intermediate Similarity | NPC225384 |
0.8151 | Intermediate Similarity | NPC246869 |
0.8151 | Intermediate Similarity | NPC138777 |
0.8146 | Intermediate Similarity | NPC80098 |
0.8141 | Intermediate Similarity | NPC12006 |
0.8141 | Intermediate Similarity | NPC158635 |
0.8141 | Intermediate Similarity | NPC182350 |
0.8141 | Intermediate Similarity | NPC229882 |
0.8141 | Intermediate Similarity | NPC35160 |
0.8141 | Intermediate Similarity | NPC162569 |
0.8138 | Intermediate Similarity | NPC469549 |
0.8138 | Intermediate Similarity | NPC253595 |
0.8137 | Intermediate Similarity | NPC478265 |
0.8133 | Intermediate Similarity | NPC324262 |
0.8133 | Intermediate Similarity | NPC62800 |
0.8133 | Intermediate Similarity | NPC220942 |
0.8125 | Intermediate Similarity | NPC103533 |
0.8113 | Intermediate Similarity | NPC10205 |
0.8113 | Intermediate Similarity | NPC38699 |
0.8112 | Intermediate Similarity | NPC126991 |
0.8112 | Intermediate Similarity | NPC123704 |
0.8112 | Intermediate Similarity | NPC83218 |
0.811 | Intermediate Similarity | NPC469419 |
0.8101 | Intermediate Similarity | NPC44730 |
0.8098 | Intermediate Similarity | NPC327694 |
0.8095 | Intermediate Similarity | NPC327204 |
0.8095 | Intermediate Similarity | NPC471066 |
0.8095 | Intermediate Similarity | NPC471095 |
0.8095 | Intermediate Similarity | NPC323379 |
0.8089 | Intermediate Similarity | NPC140151 |
0.8086 | Intermediate Similarity | NPC293568 |
0.8086 | Intermediate Similarity | NPC117943 |
0.8085 | Intermediate Similarity | NPC11724 |
0.8082 | Intermediate Similarity | NPC469705 |
0.8082 | Intermediate Similarity | NPC470122 |
0.8082 | Intermediate Similarity | NPC17968 |
0.8067 | Intermediate Similarity | NPC310252 |
0.8067 | Intermediate Similarity | NPC84789 |
0.8067 | Intermediate Similarity | NPC100558 |
0.8067 | Intermediate Similarity | NPC170718 |
0.8067 | Intermediate Similarity | NPC302583 |
0.8065 | Intermediate Similarity | NPC97240 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC96599 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.8528 | High Similarity | NPD7685 | Pre-registration |
0.8013 | Intermediate Similarity | NPD7266 | Discontinued |
0.7791 | Intermediate Similarity | NPD4381 | Clinical (unspecified phase) |
0.7692 | Intermediate Similarity | NPD6190 | Approved |
0.7688 | Intermediate Similarity | NPD8055 | Clinical (unspecified phase) |
0.7628 | Intermediate Similarity | NPD4628 | Phase 3 |
0.7616 | Intermediate Similarity | NPD7966 | Clinical (unspecified phase) |
0.7545 | Intermediate Similarity | NPD7199 | Phase 2 |
0.7529 | Intermediate Similarity | NPD7228 | Approved |
0.7529 | Intermediate Similarity | NPD3818 | Discontinued |
0.75 | Intermediate Similarity | NPD8455 | Phase 2 |
0.7485 | Intermediate Similarity | NPD7804 | Clinical (unspecified phase) |
0.7484 | Intermediate Similarity | NPD6143 | Clinical (unspecified phase) |
0.7439 | Intermediate Similarity | NPD37 | Approved |
0.7425 | Intermediate Similarity | NPD6234 | Discontinued |
0.7423 | Intermediate Similarity | NPD4380 | Phase 2 |
0.741 | Intermediate Similarity | NPD4967 | Phase 2 |
0.741 | Intermediate Similarity | NPD4965 | Approved |
0.741 | Intermediate Similarity | NPD4966 | Approved |
0.7403 | Intermediate Similarity | NPD6653 | Approved |
0.7384 | Intermediate Similarity | NPD7054 | Approved |
0.7365 | Intermediate Similarity | NPD7075 | Discontinued |
0.7353 | Intermediate Similarity | NPD7184 | Clinical (unspecified phase) |
0.7341 | Intermediate Similarity | NPD7472 | Approved |
0.7341 | Intermediate Similarity | NPD7074 | Phase 3 |
0.7338 | Intermediate Similarity | NPD6355 | Discontinued |
0.7333 | Intermediate Similarity | NPD6007 | Clinical (unspecified phase) |
0.7333 | Intermediate Similarity | NPD5647 | Approved |
0.7326 | Intermediate Similarity | NPD7799 | Discontinued |
0.7325 | Intermediate Similarity | NPD6003 | Clinical (unspecified phase) |
0.7325 | Intermediate Similarity | NPD6006 | Clinical (unspecified phase) |
0.7325 | Intermediate Similarity | NPD6004 | Phase 3 |
0.7325 | Intermediate Similarity | NPD6002 | Phase 3 |
0.7325 | Intermediate Similarity | NPD6005 | Phase 3 |
0.732 | Intermediate Similarity | NPD6663 | Approved |
0.7314 | Intermediate Similarity | NPD4338 | Clinical (unspecified phase) |
0.731 | Intermediate Similarity | NPD9545 | Approved |
0.7305 | Intermediate Similarity | NPD4868 | Clinical (unspecified phase) |
0.7301 | Intermediate Similarity | NPD1653 | Approved |
0.7285 | Intermediate Similarity | NPD5736 | Approved |
0.7278 | Intermediate Similarity | NPD7879 | Clinical (unspecified phase) |
0.7273 | Intermediate Similarity | NPD8313 | Approved |
0.7273 | Intermediate Similarity | NPD8312 | Approved |
0.7257 | Intermediate Similarity | NPD7251 | Discontinued |
0.7257 | Intermediate Similarity | NPD6559 | Discontinued |
0.7256 | Intermediate Similarity | NPD7458 | Discontinued |
0.7255 | Intermediate Similarity | NPD3764 | Approved |
0.7235 | Intermediate Similarity | NPD8127 | Discontinued |
0.7226 | Intermediate Similarity | NPD230 | Phase 1 |
0.7216 | Intermediate Similarity | NPD7808 | Phase 3 |
0.72 | Intermediate Similarity | NPD6797 | Phase 2 |
0.7197 | Intermediate Similarity | NPD7033 | Discontinued |
0.7186 | Intermediate Similarity | NPD7096 | Clinical (unspecified phase) |
0.7159 | Intermediate Similarity | NPD7240 | Approved |
0.7134 | Intermediate Similarity | NPD7097 | Phase 1 |
0.7134 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.7126 | Intermediate Similarity | NPD6801 | Discontinued |
0.7117 | Intermediate Similarity | NPD8389 | Clinical (unspecified phase) |
0.7117 | Intermediate Similarity | NPD7004 | Clinical (unspecified phase) |
0.7107 | Intermediate Similarity | NPD5762 | Approved |
0.7107 | Intermediate Similarity | NPD5763 | Approved |
0.7081 | Intermediate Similarity | NPD8166 | Discontinued |
0.7081 | Intermediate Similarity | NPD1878 | Clinical (unspecified phase) |
0.7073 | Intermediate Similarity | NPD6273 | Approved |
0.7039 | Intermediate Similarity | NPD3094 | Phase 2 |
0.7039 | Intermediate Similarity | NPD6362 | Approved |
0.7032 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.7025 | Intermediate Similarity | NPD4978 | Clinical (unspecified phase) |
0.7019 | Intermediate Similarity | NPD7421 | Clinical (unspecified phase) |
0.7006 | Intermediate Similarity | NPD7028 | Phase 2 |
0.7 | Intermediate Similarity | NPD1091 | Approved |
0.6994 | Remote Similarity | NPD7236 | Approved |
0.6987 | Remote Similarity | NPD6233 | Phase 2 |
0.6982 | Remote Similarity | NPD7819 | Suspended |
0.6975 | Remote Similarity | NPD6398 | Clinical (unspecified phase) |
0.6957 | Remote Similarity | NPD970 | Clinical (unspecified phase) |
0.6941 | Remote Similarity | NPD8443 | Clinical (unspecified phase) |
0.6928 | Remote Similarity | NPD2797 | Approved |
0.6923 | Remote Similarity | NPD1934 | Approved |
0.6923 | Remote Similarity | NPD6798 | Discontinued |
0.6923 | Remote Similarity | NPD3268 | Approved |
0.691 | Remote Similarity | NPD7993 | Clinical (unspecified phase) |
0.6895 | Remote Similarity | NPD7435 | Discontinued |
0.6893 | Remote Similarity | NPD5844 | Phase 1 |
0.6887 | Remote Similarity | NPD3092 | Approved |
0.6886 | Remote Similarity | NPD7239 | Suspended |
0.6885 | Remote Similarity | NPD8397 | Clinical (unspecified phase) |
0.6882 | Remote Similarity | NPD5761 | Phase 2 |
0.6882 | Remote Similarity | NPD5760 | Phase 2 |
0.6882 | Remote Similarity | NPD2393 | Clinical (unspecified phase) |
0.6875 | Remote Similarity | NPD7473 | Discontinued |
0.6875 | Remote Similarity | NPD1510 | Phase 2 |
0.6871 | Remote Similarity | NPD3750 | Approved |
0.6868 | Remote Similarity | NPD8150 | Discontinued |
0.6868 | Remote Similarity | NPD8434 | Phase 2 |
0.6864 | Remote Similarity | NPD7411 | Suspended |
0.6859 | Remote Similarity | NPD8319 | Approved |
0.6859 | Remote Similarity | NPD8320 | Phase 1 |
0.6852 | Remote Similarity | NPD1549 | Phase 2 |
0.6848 | Remote Similarity | NPD6799 | Approved |
0.6842 | Remote Similarity | NPD1608 | Approved |
0.6842 | Remote Similarity | NPD3817 | Phase 2 |
0.6842 | Remote Similarity | NPD5402 | Approved |
0.6839 | Remote Similarity | NPD2861 | Phase 2 |
0.6836 | Remote Similarity | NPD3751 | Discontinued |
0.6835 | Remote Similarity | NPD4140 | Approved |
0.6831 | Remote Similarity | NPD6685 | Approved |
0.6826 | Remote Similarity | NPD5403 | Approved |
0.6818 | Remote Similarity | NPD6167 | Clinical (unspecified phase) |
0.6818 | Remote Similarity | NPD6166 | Phase 2 |
0.6818 | Remote Similarity | NPD6168 | Clinical (unspecified phase) |
0.681 | Remote Similarity | NPD1652 | Phase 2 |
0.6807 | Remote Similarity | NPD2532 | Approved |
0.6807 | Remote Similarity | NPD2534 | Approved |
0.6807 | Remote Similarity | NPD4378 | Clinical (unspecified phase) |
0.6807 | Remote Similarity | NPD2533 | Approved |
0.6806 | Remote Similarity | NPD7497 | Discontinued |
0.6805 | Remote Similarity | NPD6599 | Discontinued |
0.6802 | Remote Similarity | NPD7930 | Approved |
0.68 | Remote Similarity | NPD6232 | Discontinued |
0.6792 | Remote Similarity | NPD5735 | Approved |
0.6792 | Remote Similarity | NPD5123 | Clinical (unspecified phase) |
0.6792 | Remote Similarity | NPD5124 | Phase 1 |
0.679 | Remote Similarity | NPD1550 | Clinical (unspecified phase) |
0.679 | Remote Similarity | NPD1552 | Clinical (unspecified phase) |
0.6784 | Remote Similarity | NPD1465 | Phase 2 |
0.6784 | Remote Similarity | NPD2801 | Approved |
0.6772 | Remote Similarity | NPD7237 | Clinical (unspecified phase) |
0.6768 | Remote Similarity | NPD4110 | Phase 3 |
0.6768 | Remote Similarity | NPD4109 | Clinical (unspecified phase) |
0.6765 | Remote Similarity | NPD7615 | Clinical (unspecified phase) |
0.6755 | Remote Similarity | NPD5126 | Approved |
0.6755 | Remote Similarity | NPD5125 | Phase 3 |
0.6753 | Remote Similarity | NPD7585 | Approved |
0.6752 | Remote Similarity | NPD5952 | Clinical (unspecified phase) |
0.6748 | Remote Similarity | NPD2424 | Discontinued |
0.6748 | Remote Similarity | NPD5958 | Discontinued |
0.6738 | Remote Similarity | NPD6534 | Approved |
0.6738 | Remote Similarity | NPD6535 | Approved |
0.6737 | Remote Similarity | NPD6777 | Approved |
0.6737 | Remote Similarity | NPD6780 | Approved |
0.6737 | Remote Similarity | NPD6776 | Approved |
0.6737 | Remote Similarity | NPD6778 | Approved |
0.6737 | Remote Similarity | NPD6779 | Approved |
0.6737 | Remote Similarity | NPD6782 | Approved |
0.6737 | Remote Similarity | NPD6781 | Approved |
0.6736 | Remote Similarity | NPD7999 | Approved |
0.6728 | Remote Similarity | NPD2796 | Approved |
0.6728 | Remote Similarity | NPD2935 | Discontinued |
0.6723 | Remote Similarity | NPD7852 | Clinical (unspecified phase) |
0.672 | Remote Similarity | NPD7700 | Phase 2 |
0.672 | Remote Similarity | NPD7699 | Phase 2 |
0.6719 | Remote Similarity | NPD7680 | Approved |
0.6718 | Remote Similarity | NPD8151 | Discontinued |
0.6707 | Remote Similarity | NPD6674 | Discontinued |
0.6707 | Remote Similarity | NPD5401 | Approved |
0.6705 | Remote Similarity | NPD3787 | Discontinued |
0.6705 | Remote Similarity | NPD3882 | Suspended |
0.6705 | Remote Similarity | NPD7768 | Phase 2 |
0.6701 | Remote Similarity | NPD7583 | Approved |
0.669 | Remote Similarity | NPD2067 | Discontinued |
0.6687 | Remote Similarity | NPD5058 | Phase 3 |
0.6687 | Remote Similarity | NPD6652 | Clinical (unspecified phase) |
0.6686 | Remote Similarity | NPD5494 | Approved |
0.6685 | Remote Similarity | NPD6765 | Approved |
0.6685 | Remote Similarity | NPD6764 | Approved |
0.6684 | Remote Similarity | NPD7874 | Approved |
0.6684 | Remote Similarity | NPD7875 | Clinical (unspecified phase) |
0.6667 | Remote Similarity | NPD2798 | Approved |
0.6667 | Remote Similarity | NPD5740 | Clinical (unspecified phase) |
0.6667 | Remote Similarity | NPD7090 | Clinical (unspecified phase) |
0.6667 | Remote Similarity | NPD4062 | Phase 3 |
0.6667 | Remote Similarity | NPD3749 | Approved |
0.6667 | Remote Similarity | NPD6085 | Phase 2 |
0.6667 | Remote Similarity | NPD9265 | Clinical (unspecified phase) |
0.6667 | Remote Similarity | NPD2799 | Discontinued |
0.665 | Remote Similarity | NPD7783 | Phase 2 |
0.665 | Remote Similarity | NPD7782 | Clinical (unspecified phase) |
0.6647 | Remote Similarity | NPD5353 | Approved |
0.6646 | Remote Similarity | NPD3027 | Phase 3 |
0.6646 | Remote Similarity | NPD7095 | Approved |
0.6645 | Remote Similarity | NPD3019 | Approved |
0.6645 | Remote Similarity | NPD2932 | Approved |
0.6645 | Remote Similarity | NPD1876 | Approved |
0.6645 | Remote Similarity | NPD17 | Approved |
0.6644 | Remote Similarity | NPD7157 | Approved |
0.6632 | Remote Similarity | NPD7697 | Approved |
0.6632 | Remote Similarity | NPD7698 | Approved |
0.6632 | Remote Similarity | NPD7696 | Phase 3 |
0.6626 | Remote Similarity | NPD6100 | Approved |
0.6626 | Remote Similarity | NPD6099 | Approved |
0.6626 | Remote Similarity | NPD2438 | Suspended |
0.6625 | Remote Similarity | NPD4060 | Phase 1 |
0.6625 | Remote Similarity | NPD3619 | Clinical (unspecified phase) |
0.6625 | Remote Similarity | NPD1240 | Approved |
0.6625 | Remote Similarity | NPD3620 | Phase 2 |
0.6624 | Remote Similarity | NPD9494 | Approved |
0.6623 | Remote Similarity | NPD9269 | Phase 2 |
0.6623 | Remote Similarity | NPD3091 | Approved |
0.662 | Remote Similarity | NPD5765 | Approved |
PubChem CID   | 23955893 |
ChEMBL   | CHEMBL505478 |
ZINC   |
Molecular Weight:   | 552.18 |
ALogP:   | -3.4251 |
MLogP:   | 2.89 |
XLogP:   | 0.584 |
# Rotatable Bonds:   | 17 |
Polar Surface Area:   | 201.67 |
# H-Bond Aceptor:   | 12 |
# H-Bond Donor:   | 6 |
# Rings:   | 4 |
# Heavy Atoms:   | 39 |